Get started
Author

Carlotta Camilli

Observed names: C Camilli, C. Camilli, Camilli, C
ORCID: 0000-0002-4858-336X
Observed ORCID: 0000-0002-4858-336X
OpenAlex ID: A5091820458
LRG1: an emerging player in disease pathogenesis
2022 · Carlotta Camilli, Alexandra E. Hoeh, et al. · Journal of Biomedical Science · 210
PDF
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors
2018 · Luca Urbani, Carlotta Camilli, et al. · Nature Communications · 106
PDF
Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis
2021 · Mahak Singhal, Nicolas Gengenbacher, et al. · Science Translational Medicine · 89
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency
2021 · Marie N. O’Connor, David M. Kallenberg, et al. · Med · 72
Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice
2015 · Laura Pelosi, Maria Grazia Berardinelli, et al. · Human Molecular Genetics · 72
PDF
Long-term cryopreservation of decellularised oesophagi for tissue engineering clinical application
2017 · Luca Urbani, Panagiotis Maghsoudlou, et al. · PLoS ONE · 67
PDF
Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
2021 · Faiza Javaid, Camilla Pilotti, et al. · RSC Chemical Biology · 36
PDF
The disruptive role of LRG1 on the vasculature and perivascular microenvironment
2024 · Athina Dritsoula, Carlotta Camilli, et al. · Frontiers in Cardiovascular Medicine · 35
Non-Invasive Longitudinal Bioluminescence Imaging of Human Mesoangioblasts in Bioengineered Esophagi
2019 · Claire Crowley, Colin R. Butler, et al. · Tissue Engineering Part C Methods · 9
PDF
Derivation, expansion and cryopreservation of primary fetal organoids from second and third trimester human amniotic fluid cells
2025 · Giuseppe Calà, Giorgia D’Ariano, et al. · Nature Protocols · 2
D1.4 Oesophageal tissue engineering: preliminary evaluation of a 2 stage surgical approach in a mouse model
2017 · F Scottoni, L Urbani, et al. · 2
Abstract 3180: Targeting LRG1 to normalize tumor vasculature and enhance therapeutic efficacy
2022 · John Greenwood, Carlotta Camilli, et al. · Cancer Research · 1
Development of a bioartificial oesophagus engineered with primary mesoangioblasts, neural and epithelial cells for preclinical studies
2017 · L. Urbani, C. Camilli, et al. · Cytotherapy · 1
Op‐1 Artificial Oesophagus Engineering in a 3d Dynamic Culture
2015 · C. Camilli, L. Urbani, et al. · Journal of Pediatric Gastroenterology and Nutrition · 1
Derivation of primary fetal epithelial organoids from cryopreserved human amniotic fluid cells
2026 · Giorgia D’Ariano, Gloria Ji Zhang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
ABO blood groups and ageing-related outcomes: Insights from a narrative review
2026 · Carmela Rita Balistreri, Alessia Di Salvo, et al. · Mechanisms of Ageing and Development
Abstract 391: Lrg1 blockade modulates the tumor immune microenvironment and improves the efficacy of cancer therapeutics
2020 · Carlotta Camilli, Camilla Pilotti, et al. · Cancer Research
LRG1 Destabilizes Tumor Vessels and Restricts Immunotherapeutic Potency
2020 · Marie N. O’Connor, David Kallenberg, et al. · SSRN Electronic Journal
Development of a bioengineered oesophagus as a novel therapy for oesophageal atresia
2018 · Carlotta Camilli · UCL Discovery (University College London)
Bioluminescence Imaging for Live Cell Tracking in Tissue Engineering Applications
2015 · Crowley, C, Butler, C, et al. · UCL Discovery (University College London)
Development of an Artificial Oesophagus Engineered with Mesoangioblasts in a Peristaltic 3d Dynamic Culture
2015 · Urbani, L, Camilli, C, et al. · UCL Discovery (University College London)
Reconstruction of Gut Muscle Layer: Mesoangioblasts' Delivery Optimization in Decellularised Scaffolds
2015 · Urbani, L, Camilli, C, et al. · UCL Discovery (University College London)
Works count: 22
Citation count: 703
H-index: 9
I10-index: 8
Year
Topic
Type